Health Care & Life Sciences » Pharmaceuticals | Pacira Pharmaceuticals Inc.

Pacira Pharmaceuticals Inc. | Ownership

Companies that own Pacira Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Consonance Capital Management LP
3,753,834
9.16%
1,118,918
9.46%
06/30/2018
The Vanguard Group, Inc.
3,311,603
8.09%
105,662
0.01%
06/30/2018
Partner Fund Management LP
3,148,457
7.69%
1,420,051
2.57%
06/30/2018
BlackRock Fund Advisors
3,080,562
7.52%
47,977
0.01%
06/30/2018
HealthCor Management LP
2,855,213
6.97%
555,213
3.89%
06/30/2018
Macquarie Investment Management Business Trust
2,321,125
5.67%
768,011
0.2%
06/30/2018
T. Rowe Price Associates, Inc.
1,664,554
4.05%
-141,714
0.01%
06/30/2018
PointState Capital LP
1,622,684
3.96%
-415,469
0.9%
06/30/2018
venBio Select Advisor LLC
1,460,610
3.57%
-254,462
2.35%
06/30/2018
Elk Creek Partners LLC
1,369,060
3.34%
366,749
3.27%
06/30/2018

About Pacira Pharmaceuticals

View Profile
Address
5 Sylvan Way
Parsippany New Jersey 07054
United States
Employees -
Website http://www.pacira.com
Updated 07/08/2019
Pacira Pharmaceuticals, Inc. is a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.